10-Minute Speech Practice That Doesn't Require Sitting Still

Last updated 2026-07-11

What is a letter of medical necessity for AAC, and why does it matter?

A letter of medical necessity (LMN) is the clinical argument that stands between your child and an insurer paying for an AAC device. It tells the insurance company, in their own language, exactly why this specific device is medically required rather than merely convenient.

Without a strong LMN, claims get denied. The American Speech-Language-Hearing Association estimates that AAC devices can cost anywhere from a few hundred dollars for simple hardware to over $10,000 for high-tech speech-generating devices, so the money at stake is real ^[1]. Insurers, including Medicaid and private payers operating under the framework set by the Assistive Technology Act of 1998 (29 U.S.C. § 3001 et seq.), require the LMN to justify medical coverage rather than treating the device as a consumer product ^[2].

The letter is not a vague statement of need. It is a structured clinical document, and the gap between approval and denial usually comes down to whether the writer understood the insurer's specific criteria. Most denials trace back to one of three problems: missing functional data, no evidence of device trials, or a diagnosis listed without connecting it to a communication deficit.

Think of the LMN as a legal brief. It has to anticipate objections and answer them before the reviewer raises them.

Who should write the letter of medical necessity for an AAC device?

The letter must come from a licensed speech-language pathologist (SLP), full stop. Some insurers also require a physician's signature co-signing the SLP's evaluation, but the clinical content has to originate with the SLP who ran the AAC assessment ^[3].

If a pediatrician writes the letter alone, most insurers reject it, because the physician usually lacks the scope of practice to perform AAC feature-matching. The physician documents the underlying diagnosis and medical necessity from a medical standpoint. The physician does not recommend a specific device.

Here is how the team typically divides responsibilities:

If your child's SLP has never written an AAC LMN, that is fine, but point them to ASHA's guidance on AAC funding documentation, which walks through the requirements ^[1]. Several AAC device manufacturers run funding support teams who will review a draft LMN at no charge, and that review catches gaps before submission.

For families working with an early intervention program, the EI team sometimes handles the referral. Once a child ages out of Part C services (typically at age 3), the family has to work through private insurance, Medicaid, or school-based funding on its own.

What must be included in a letter of medical necessity for AAC?

There is no single universal template, but the elements below appear in almost every insurer's funding criteria. Miss one and expect a denial, or a request for more information that delays the process by weeks.

1. Patient demographics and diagnosis Full legal name, date of birth, insurance ID, and the specific ICD-10 diagnosis codes that explain why the patient has a communication impairment. For a child with autism, that is typically F84.0. For childhood apraxia of speech, R47.01 or F80.0 depending on severity and context ^[4]. The diagnosis code alone is not enough. The letter has to explain how the diagnosis causes the functional communication deficit.

2. Description of current communication status This is where most letters fall short. The SLP needs to describe, with specifics and standardized assessment data, what the patient cannot do. That means citing actual scores from tests like the Clinical Evaluation of Language Fundamentals (CELF-5), the Preschool Language Scales (PLS-5), or the Communication Matrix ^[5]. "The patient has limited verbal output" gets you nowhere. "The patient scored at the 1st percentile for expressive language on the PLS-5 administered on [date] and produces fewer than 10 consistent functional words" moves a claim forward.

3. Explanation of why existing methods are insufficient The insurer wants to know why a lower-cost solution will not work. Did the patient try PECS and plateau? Did low-tech communication boards fail because the patient's motor planning needs exceed what static symbols can support? This is where an apraxia of speech or childhood apraxia of speech diagnosis earns its place, because the motor-speech component gives a clear medical reason that a speech-generating device is necessary rather than nice to have.

4. Device trial documentation Most insurers require evidence that the recommended device was actually trialed and was the best match. The trial should name the specific device, model, and software, the dates and duration of the trial, the settings where it happened, and what the clinician observed. A trial of two or three devices with comparative notes beats a single trial.

5. Feature-matching rationale The SLP explains why this device, with this vocabulary set and access method, fits the patient's motor, cognitive, visual, and linguistic profile. Reference the patient's access needs (direct selection, eye gaze, switch scanning) and explain why the recommended device accommodates them.

6. Prognosis and functional benefit statement State clearly that the patient is expected to benefit from the device, and name the functional gains anticipated. Peer-reviewed research that supports AAC for the patient's specific profile strengthens this section a lot. A 2006 study in the American Journal of Speech-Language Pathology found no evidence that AAC impedes speech development in people with developmental disabilities, and may support it ^[6], which directly answers a common insurer objection.

7. Physician attestation A co-signature from the prescribing physician stating the device is medically necessary closes the letter. Some insurers require this on a separate physician letter. Others accept a co-signature on the SLP letter.

How long should the letter be, and what format works best?

Length matters less than completeness. A well-organized four-page letter beats a disorganized eight-page one every time. Most strong LMNs run three to five pages of single-spaced text plus supporting documentation attached as exhibits.

Use plain numbered or lettered headers that mirror the insurer's own criteria language when you can find it. Many Medicaid programs publish their AAC coverage policies online, and matching their section structure makes it easier for the reviewer to check boxes.

Attach these as separate exhibits rather than burying them in the letter:

• The full standardized assessment report
• Device trial notes
• Any prior authorization denials and appeal outcomes
• Physician's prescription or referral
• A photo of the patient using the trialed device, if the insurer accepts it

Keep the opening paragraph tight. The first sentence should state the patient's name, age, diagnosis, and the specific device being requested. Reviewers read dozens of these. If the core request is buried on page two, you have created friction that hurts the patient.

What language do insurers actually want to see?

Insurers, especially Medicare and Medicaid, use the term "speech-generating device" (SGD), not AAC. Medicare covers SGDs as Durable Medical Equipment (DME) under the Medicare Benefit Policy Manual, Chapter 15 ^[7]. When you write for a Medicare or Medicare Advantage beneficiary, that exact terminology matters, because coverage criteria are tied to it.

For Medicare, the patient must have a severe expressive speech impairment due to a chronic medical condition, must be able to benefit from a device in their home, and must not be able to functionally communicate with natural speech alone. Address those three criteria explicitly, almost as a checklist.

For Medicaid, coverage varies by state. Most state Medicaid programs cover AAC under the Early and Periodic Screening, Diagnostic and Treatment (EPSDT) benefit for children under 21, which requires states to cover all medically necessary services regardless of whether those services are covered for adults ^[8]. That is a powerful lever. If a state Medicaid plan denies an AAC device for a child under 21, the EPSDT mandate is the basis for the appeal.

For private insurance, align the letter with the plan's prior authorization criteria, which you can request from the insurer's provider relations line before you write a word. Some plans follow Medicare's SGD criteria almost exactly. Others have their own language around "functional communication" and "least restrictive alternative."

One phrase worth including verbatim: the American Academy of Pediatrics states that "communication is a basic human right" and recommends clinicians advocate for AAC access as part of a child's medical care ^[9]. Quoting AAP policy in a letter to a private insurer carries weight.

What are the most common reasons AAC letters get denied?

Getting denied is not the end. It is common, and most successful AAC approvals come after at least one denial and appeal. Knowing the triggers helps you write a stronger letter the first time.

"Not medically necessary" is the most common denial reason. It almost always means the letter did not connect the diagnosis to the functional deficit clearly enough, or the functional deficit description lacked standardized data. The fix is adding assessment scores and naming the specific daily activities the patient cannot perform without AAC.

"Device not the least costly alternative" means the insurer thinks a cheaper device would work. The feature-matching section has to spell out why lower-cost options were trialed and found insufficient for this patient.

"No documented device trial" is a process failure. If the SLP cannot produce dated trial notes, the claim has no foundation. Trial documentation does not need to be elaborate. It needs to exist and be attached.

"Diagnosis does not support coverage" happens when a code is submitted without a narrative. A child with autism whose letter only says "F84.0" without explaining the specific communication impairment tied to that diagnosis hits this wall.

Expired or missing signatures cause administrative denials. Some insurers require physician signatures dated within 30 or 60 days of submission. Check this before mailing.

If a letter is denied, request the denial in writing with the specific criteria not met. That document is your blueprint for the appeal.

How does the appeals process work if the letter is denied?

Under the Affordable Care Act, all non-grandfathered private health plans must offer an internal appeals process and access to external review ^[10]. A denial is never truly final on the first round.

For internal appeals, you typically have 180 days from the denial to file. The appeal should include a revised or expanded LMN that answers each denial reason, a letter from the prescribing physician that goes beyond a co-signature to argue medical necessity, peer-reviewed research citations, and a statement from the family documenting the functional impact on daily life.

For external review, an independent reviewer with no ties to the insurer evaluates the claim. External reviewers who specialize in assistive technology tend to rule for the patient more often than internal reviews do, though good national data on AAC-specific external review outcomes is limited.

Medicaid appeals follow a different path. Families can request a fair hearing, and for children under 21 the EPSDT mandate is again the core argument ^[8]. State-level disability rights organizations often provide free legal help for Medicaid fair hearings involving AAC, and the Assistive Technology Act programs in each state (funded under 29 U.S.C. § 3001) can provide advocacy support ^[2].

Do not wait to start the appeal. The clock runs from the denial date, and AAC delays have real consequences for a child's language development.

Does Medicaid cover AAC devices for children, and what does the letter need to say differently?

Yes, Medicaid covers AAC devices for children, and the EPSDT mandate makes the coverage argument stronger for pediatric patients than for adults. Under EPSDT, state Medicaid programs must cover any service that is "medically necessary" to correct or ameliorate a physical or mental condition in a child under 21, regardless of whether that service is listed in the state plan ^[8].

The phrase "correct or ameliorate" is doing a lot of work there. The "ameliorate" standard is intentionally broad, meaning a service does not have to cure a condition, only improve or compensate for it. An AAC device clearly meets that standard for a child with a severe expressive communication disorder.

For a Medicaid LMN, invoke EPSDT by name and cite the federal requirement. Note the child's age and that the request falls within the EPSDT benefit period. Some SLPs skip this and write the same letter they would for a private insurer. That leaves your strongest argument on the table.

State Medicaid programs also vary on whether they require a separate AT evaluation by a certified assistive technology professional (ATP). Check your state's Medicaid provider manual before submitting. Roughly 20 states require the ATP credential on the evaluation for high-cost devices, though that number shifts as states update their policies.

What does a sample LMN outline look like?

This is not a fill-in-the-blank template, because a template without real assessment data reads like a form letter and gets flagged. But this outline gives the SLP a structure to build from.

---

[SLP's letterhead, license number, date]

RE: Medical Necessity for Speech-Generating Device Patient: [Full name, DOB, Insurance ID] Requesting Provider: [SLP name, credentials, NPI] Prescribing Physician: [Name, NPI, specialty]

Section 1: Introduction and Request State the specific device requested (manufacturer, model, software/vocabulary system) and the diagnosis codes.

Section 2: Diagnosis and Medical History Explain the diagnosed condition(s) and how they produce a severe expressive communication disorder. Reference the physician's records. Include relevant co-occurring conditions (motor impairment, cognitive profile, sensory needs).

Section 3: Current Communication Status Standardized assessment data. List every test administered, date, and relevant subtest scores. Describe functional communication: what the patient cannot do in daily life, at school, with family, in medical settings.

Section 4: Prior and Current Interventions Document the history of speech therapy. What has been tried? What were the outcomes? Why has natural speech development not progressed to functional communication?

Section 5: Device Trials For each device trialed: name, dates, access method used, vocabulary system, observed patient performance, and why this device was or was not selected. The recommended device should show the strongest functional gains.

Section 6: Feature Matching and Justification for Requested Device Connect patient needs to device features one by one. Access method, vocabulary depth, language representation, portability, durability, and customizability.

Section 7: Functional Benefit and Prognosis Anticipated gains. Timeline for reassessment. Cite relevant research.

Section 8: Summary and Request Restate the request clearly. Include the device cost if the insurer requires it.

Signatures: SLP (with date and license number), Physician (with date and NPI)

---

One practical note: the SLP should keep a copy of everything submitted and log the submission date and method (mail, fax, portal) in the patient file. You will need that record if the insurer claims they never received it.

How can parents support the SLP in writing a stronger letter?

Parents are often the best source of functional communication data, and most SLPs welcome detailed input. A written communication diary from the parent, covering two to four weeks before the assessment, is genuinely useful. It captures things like how many times per day the child communicated a want or need, how often communication attempts were misunderstood, whether the child got frustrated or withdrew, and which strategies the family already tried.

Parents can also pull together the child's school IEP if one exists. The IEP's present levels of performance (PLOP) section often contains language about communication deficits that the SLP can quote directly in the LMN, with the family's permission.

If your child has been using any low-tech supports, take photos. Visual evidence of a child working with a PECS board or a communication book, and the clear limits of that approach, is something some insurers accept as part of the documentation package.

For families using supplemental tools like the Little Words app alongside therapy, the SLP may be able to reference data from that kind of app-based practice as supplemental evidence of the child's communication attempts and patterns outside clinical sessions. Any real-world data about communication frequency and modality helps build the picture.

Ask your SLP whether the device manufacturer has a funding support team. Companies like Tobii Dynavox, PRC-Saltillo, and Lingraphica employ staff whose whole job is helping families get through the funding process. They will not write the letter for you, but they will review it and flag problems before submission.

How long does the AAC funding process typically take?

The honest answer is longer than it should. From initial assessment to device delivery, families commonly wait three to nine months, and that range is wide because so much depends on the insurer, whether an appeal is needed, and how fast documentation comes together.

Here is a rough breakdown of the major steps:

Medicare Advantage plans must generally make standard prior authorization decisions within 14 days and expedited requests within 72 hours ^[7]. Private insurers vary but are generally required by state law to decide within 30 to 45 calendar days for standard prior authorizations.

If the timeline stretches past six months, families can ask the insurer for an expedited review on the grounds that the delay is causing harm, such as missed developmental windows for language acquisition. Documenting that harm in writing, with the SLP's clinical opinion, strengthens the request.

For families pursuing autism spectrum speech therapy, the window between ages 2 and 5 is when language acquisition responds best to intervention, which makes delays in AAC access genuinely costly in developmental terms ^[11].

Are there free resources or templates to help write the letter?

Yes, and knowing where to find them saves time. These are real, free resources:

ASHA's AAC funding resources: ASHA maintains a funding resources page with state-by-state Medicaid coverage information and documentation guidelines ^[1].

State assistive technology programs: Every state has an AT program funded under the Assistive Technology Act. These programs run device lending libraries (useful for trials), offer funding assistance, and sometimes help directly with LMN documentation. Find your state's program through the AT3 Center ^[2].

Device manufacturer funding teams: Tobii Dynavox, PRC-Saltillo, and Lingraphica all offer funding navigation support. They are motivated to help because it drives sales, but the practical help is real.

State disability rights organizations: State Protection and Advocacy (P&A) agencies provide free legal help for AAC funding appeals. The National Disability Rights Network can point you to your state's P&A.

AAC research archives: Federally funded research centers on AAC have published guidance on funding and documentation, and their materials are publicly available through federal archives.

One warning about generic templates you find through a web search: a template that is not tailored to the insurer's criteria and the patient's assessment data is worse than useless. It signals to the reviewer that the letter was not written for this patient, and some reviewers deny on that basis alone.

Frequently asked questions

Can a parent write a letter of medical necessity for AAC themselves?

No. The letter must come from a licensed speech-language pathologist, and most insurers also require a physician co-signature. A parent letter can be submitted as a supporting document alongside the clinical LMN to describe functional daily-life impacts, and that supplemental statement genuinely helps, but it cannot replace the SLP's clinical documentation. If you do not currently have an SLP, contact your pediatrician for a referral or reach out to your state's early intervention program.

What ICD-10 codes are used for AAC letters of medical necessity?

Common codes include F84.0 (autism spectrum disorder), F80.1 (expressive language disorder), F80.0 (phonological disorder), R47.01 (aphasia), and F80.82 (childhood onset fluency disorder). The right code depends on the specific diagnosis. Your SLP and prescribing physician should agree on the codes before submission, because a mismatch between the physician's diagnosis and the SLP's recommended codes is a common cause of administrative denial.

Does Medicare cover AAC devices, and what are the specific requirements?

Medicare covers speech-generating devices (SGDs) as Durable Medical Equipment under Medicare Part B. The patient must have a severe expressive speech impairment due to a chronic medical condition, must be able to benefit from the device in their home environment, and must not be able to functionally communicate using natural speech alone. The LMN must use the term 'speech-generating device' and address all three criteria explicitly. The Medicare Benefit Policy Manual, Chapter 15, covers SGD coverage criteria.

What happens if the insurer says AAC is 'educational' rather than 'medical'?

This is a common denial tactic. The LMN should answer it up front by documenting that the need for AAC exists across all environments, including home, medical appointments, and community settings, not only school. Medical necessity is established by the diagnosis and functional communication deficit, not by where the device is used. If denied on educational grounds, cite the EPSDT mandate for Medicaid-enrolled children under 21, which requires coverage of medically necessary services regardless of this framing.

How often does a letter of medical necessity for AAC need to be renewed?

Most insurers require re-authorization every one to three years, or when the patient needs a device upgrade. The renewal letter follows the same format as the initial LMN but should document progress made with the current device, any changes in the patient's communication profile, and why an upgraded or replacement device is now medically necessary. Keep the original LMN and approval on file, because it becomes useful evidence for renewal requests.

Can an AAC device be covered by both Medicaid and private insurance?

Yes, through a process called coordination of benefits. Medicaid typically acts as the payer of last resort, meaning private insurance is billed first. If private insurance covers part of the cost but not all, Medicaid may cover the remaining balance for Medicaid-enrolled children. Both payers will require the LMN. Inform both insurers of the dual coverage upfront to avoid coordination disputes that delay the device.

What if a school district says they will provide AAC through the IEP instead?

A school-provided AAC device is tied to educational goals and stays at school. It cannot ethically or legally substitute for a medically necessary device the child needs at home, in medical settings, and in the community. The IEP and the medical LMN serve different purposes and are funded through different streams. Families can and should pursue both simultaneously. Document the school placement in the LMN as evidence of communication need, not as evidence that the need is already met.

How much does an AAC device typically cost, and does that affect the letter?

High-tech speech-generating devices typically cost between $3,000 and $12,000 depending on the hardware, mounting system, and software. Simpler dedicated devices with limited vocabulary can run $150 to $1,500. The LMN should include the device's cost if the insurer requires it for prior authorization, but the cost itself does not change the medical necessity argument. The argument is always about functional need, not price. Feature-matching to the patient's specific profile is what justifies a higher-cost device.

What is the role of an AAC evaluation, and how is it different from the letter itself?

The AAC evaluation is the clinical process: assessment, device trials, feature matching, and report writing. It typically takes two to four sessions and results in a formal evaluation report. The letter of medical necessity is a shorter, targeted document that summarizes the evaluation's findings in the language the insurer needs to make a coverage decision. Both documents are submitted together; the evaluation report is the exhibit, and the LMN is the argument.

Can online or telehealth speech therapy SLPs write AAC letters of medical necessity?

Yes, as long as the SLP is licensed in the state where the patient resides and can conduct a thorough AAC evaluation. Some insurers require in-person device trials, which may complicate a fully telehealth process. The SLP may need to coordinate with a local AAC lending library or device manufacturer representative to arrange hands-on trials. If you are working with an online speech therapist, ask specifically whether they have experience with AAC evaluations and funding documentation before proceeding.

What research supports including in an AAC letter of medical necessity to strengthen it?

The most frequently cited study is Millar, Light, and Schlosser (2006) in the American Journal of Speech-Language Pathology, which found no evidence that AAC inhibits speech development. Romski and Sevcik's research on AAC and language learning in children with developmental disabilities is also commonly referenced. For autism specifically, research on AAC outcomes in that population is relevant. Your SLP should select studies that match the patient's specific diagnosis and profile rather than citing generic AAC research.

What if the SLP says they have never written an AAC letter of medical necessity before?

Ask them to consult with an AAC specialist or contact the device manufacturer's funding support team for guidance before writing. ASHA's Special Interest Group 12 (AAC) has resources and a community of SLPs with funding experience. This is not a reason to find a new SLP if the therapeutic relationship is otherwise strong. Writing an LMN is a learnable skill, and many excellent clinicians simply have not encountered it before. What matters is that they are willing to do it thoroughly.

Is there a difference between an AAC letter of medical necessity for a child versus an adult?

The structure is the same, but the justification differs significantly. For adults, the EPSDT mandate does not apply, so the letter must stand on its own merits under the insurer's adult coverage criteria. Adults are more likely to have acquired conditions like ALS, stroke-related aphasia, or traumatic brain injury, and the LMN should connect the device need directly to the acquired impairment. Medicare's SGD criteria apply equally to adults and children, but Medicaid's strongest coverage protections are specific to pediatric patients under 21.

Sources

1. American Speech-Language-Hearing Association (ASHA), AAC Funding and Advocacy: ASHA estimates AAC devices range from a few hundred to over $10,000; ASHA publishes documentation guidance for AAC funding.
2. Assistive Technology Act of 1998, 29 U.S.C. § 3001, AT3 Center (State AT Programs): The Assistive Technology Act funds state AT programs that offer device lending, funding assistance, and advocacy support.
3. ASHA, Scope of Practice in Speech-Language Pathology: AAC evaluation and device recommendation fall within the SLP's scope of practice; physician co-signature documents the medical diagnosis.
4. Centers for Disease Control and Prevention, ICD-10-CM Diagnosis Codes: ICD-10 codes such as F84.0 (autism spectrum disorder) and F80.1 (expressive language disorder) are used to document diagnoses in AAC LMNs.
5. Communication Matrix, research-based communication assessment tool: The Communication Matrix is a standardized tool used by SLPs to document functional communication levels in AAC assessments.
6. Millar, D.C., Light, J.C., & Schlosser, R.W. (2006). The impact of augmentative and alternative communication intervention on speech production in individuals with developmental disabilities. American Journal of Speech-Language Pathology, 15(3), 228-237.: AAC does not impede speech development in children with developmental disabilities and may support it, per this 2006 study in the American Journal of Speech-Language Pathology.
7. Medicaid.gov, Early and Periodic Screening, Diagnostic and Treatment (EPSDT): Under EPSDT, state Medicaid programs must cover all medically necessary services for children under 21, including AAC devices, regardless of whether those services are listed in the state plan.
8. American Academy of Pediatrics (AAP), policy on communication access: The AAP states that communication is a basic human right and recommends clinicians advocate for AAC access as part of a child's medical care.
9. HealthCare.gov, Your rights to appeal a health insurance company decision: Under the Affordable Care Act, all non-grandfathered private health plans must offer an internal appeals process and access to external review.
10. National Institute on Deafness and Other Communication Disorders (NIDCD), Speech and Language Developmental Milestones: The window between ages 2 and 5 is most responsive to language intervention, making timely AAC access developmentally significant.
11. Assistive Technology Act of 1998, 29 U.S.C. § 3001 et seq.: The Assistive Technology Act of 1998 establishes the legal framework under which state AT programs and Medicaid AT coverage are structured.